Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study
Cancers · 02.04.2023 · 15 (7) · 2125
DOI: 10.3390/cancers15072125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 02.04.2023. Verfasst von Magnus Holm und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of ORL Head & Neck Surgery and Audiology, Odense University Hospital, 5000 Odense, Denmark. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Studies of primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia type 2A (MEN 2A) shows divergence in frequency, disease definition, reporting of clinical characteristics and traces of selection bias. This is a nationwide population-based retrospective study of PHPT in MEN 2A, suggesting a representative frequency, with complete reporting and a strict PHPT definition. The Danish MEN 2A cohort 1930–2021 was used. Of 204 MEN 2A cases, 16 had PHPT, resulting in a frequency of 8% (CI, 5–12). Age-related penetrance at 50 years was 8% (CI, 4–15). PHPT was seen in the American Thyroid Association moderate (ATA-MOD) and high (ATA-H) risk groups in 62% and 38% of carriers, respectively. Median age at PHPT diagnosis was 45 years (range, 21–79). A total of 75% were asymptomatic and 25% were symptomatic. Thirteen underwent parathyroid surgery, resulting in a cure of 69%, persistence in 8% and recurrence in 23%. In this first study with a clear PHPT definition and no selection bias, we found a lower frequency of PHPT and age-related penetrance, but a higher age at PHPT diagnosis than often cited. This might be affected by the Danish RET p.Cys611Tyr founder effect. Our study corroborates that PHPT in MEN 2A is often mild, asymptomatic and is associated with both ATA-MOD and ATA-H variants. Likelihood of cure is high, but recurrence is not infrequent and can occur decades after surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of ORL Head & Neck Surgery and Audiology, Odense University Hospital, 5000 Odense, Denmark.
- Steno Diabetes Center North Denmark, Aalborg University Hospital, 9100 Aalborg, Denmark.
- Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.
- Department of Endocrinology and Metabolism, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Department of ORL Head & Neck Surgery, Aarhus University Hospital, 8200 Aarhus, Denmark.
ORCID-Profile: Magnus Holm, Ulla Feldt-Rasmussen, Jes Sloth Mathiesen
Zitieren
APA
Holm, M., Vestergaard, P., Poulsen, M. M., Rasmussen, Å. K., Feldt-Rasmussen, U., Bay, M., Rolighed, L., Londero, S., Pedersen, H. B., Hahn, C. H., Rask, K. B., Nielsen, H. H., Gaustadnes, M., Rossing, M. C., Hermann, A. P., Godballe, C., & Mathiesen, J. S. (2023). Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study. Cancers, 15(7), 2125. https://doi.org/10.3390/cancers15072125
Vancouver
Holm M, Vestergaard P, Poulsen MM, Rasmussen ÅK, Feldt-Rasmussen U, Bay M, et al. Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study. Cancers. 2023;15(7):2125. doi:10.3390/cancers15072125
BibTeX
@article{Holm2023,
author = {Holm, Magnus and Vestergaard, Peter and Poulsen, Morten Møller and Rasmussen, Åse Krogh and Feldt-Rasmussen, Ulla and Bay, Mette and Rolighed, Lars and Londero, Stefano and Pedersen, Henrik Baymler and Hahn, Christoffer Holst and Rask, Klara Bay and Nielsen, Heidi Hvid and Gaustadnes, Mette and Rossing, Maria Caroline and Hermann, Anne Pernille and Godballe, Christian and Mathiesen, Jes Sloth},
title = {Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study},
journal = {Cancers},
year = {2023},
volume = {15},
number = {7},
pages = {2125},
doi = {10.3390/cancers15072125}
}
EUVIMED